Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 14, 311-314, May 1, 1954]
© 1954 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldin, A.
Right arrow Articles by Humphreys, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldin, A.
Right arrow Articles by Humphreys, S. R.

Factors Influencing the Specificity of Action of an Antileukemic Agent (Aminopterin). Time of Treatment and Dosage Schedule*

Abraham Goldin, Nathan Mantel, Samuel W. Greenhouse, John M. Venditti and Stewart R. Humphreys

( Laboratory of Chemical Pharmacology and Biometrics Section, National Cancer Institute, Bethesda, Md.{dagger})

The antileukemic specificity of action of aminopterin, defined in terms of the relative effect of drug on host and tumor, was demonstrated to vary with the time of treatment following tumor implantation and the schedule of treatment. Comparisons of the relative antileukemic effectiveness of the various treatments employed were made at equal cost in drug dose mortality response. Administration of aminopterin at 3 or 4 days following tumor implantation was more effective than earlier or later administration in increasing the survival time of leukemic mice. Two of the multiple treatment schedules employed were more effective in prolonging the survival time of the leukemic mice than any of the single treatments.

* The authors wish to acknowledge the technical assistance of Don Dennis and Ina R. Hughes.

This paper is based on experiments conducted at the United States Public Health Service Hospital, Baltimore, Maryland.

{dagger} National Institutes of Health, Public Health Service, Dept. of Health, Education, and Welfare.

Received 12/10/53.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1954 by the American Association for Cancer Research.